Literature DB >> 28120040

Is increased spinal nociception another hallmark for Parkinson's disease?

Evangelia Boura1, Maria Stamelou1,2, David Vadasz1, Vincent Ries1, Marcus M Unger1,3, Georg Kägi4, Wolfgang H Oertel1, Jens C Möller1,5, Veit Mylius6,7,8.   

Abstract

Augmented spinal nociception during the "off" phase has been observed early in Parkinson's disease further increasing with disease duration. To find out whether increased spinal nociception represents a premotor feature, experimental pain sensitivity was assessed in idiopathic REM-sleep behavior disorder (IRBD) patients with or without signs of a neurodegenerative disorder compared to early Parkinson's disease (ePD) patients and healthy controls (HC). Spinal nociception as measured by the nociceptive flexion reflex (NFR) and experimental pain sensitivity as measured by heat and electrical pain thresholds were determined in 14 IRBD, 15 ePD patients in the medication-defined "off" state and 27 HC in an explorative cohort study. No significant differences between IRBD and HC were found with regard to spinal nociception (NFR) and experimental pain sensitivity. However, IRBD patient with anosmia and/or abnormal DaTSCAN tended to increased experimental pain sensitivity. In contrast, early PD patients exhibited increased NFR responses compared to HC, and a tendency for increased spinal nociception compared to IRBD patients. Increased spinal nociception may represent an early but not a premotor, non-motor feature of PD. Whether increased pain sensitivity already presents a premotor feature should be assessed in further studies.

Entities:  

Keywords:  Nociceptive flexion reflex; Non-motor symptom; Pain sensitivity; Pain threshold; Parkinson’s disease; Premotor symptom; REM-sleep behavior disorder; Spinal nociception

Mesh:

Year:  2017        PMID: 28120040     DOI: 10.1007/s00415-016-8390-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  38 in total

Review 1.  REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP.

Authors:  Carlos H Schenck; Mark W Mahowald
Journal:  Sleep       Date:  2002-03-15       Impact factor: 5.849

2.  [Sleep-related breathing disorders--a second edition of the International Classification of Sleep Disorders (ICSD-2) of the American Academy of Sleep Medicine (AASM)].

Authors:  H-W Duchna
Journal:  Pneumologie       Date:  2006-09

Review 3.  Pain in Parkinson's disease.

Authors:  Blair Ford
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

Review 4.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

5.  Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons.

Authors:  Heiko Braak; Magdalena Sastre; Jürgen R E Bohl; Rob A I de Vos; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2007-02-09       Impact factor: 17.088

6.  REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.

Authors:  D O Claassen; K A Josephs; J E Ahlskog; M H Silber; M Tippmann-Peikert; B F Boeve
Journal:  Neurology       Date:  2010-07-28       Impact factor: 9.910

7.  Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.

Authors:  Christine Brefel-Courbon; Pierre Payoux; Claire Thalamas; Fabienne Ory; Isabelle Quelven; François Chollet; Jean Louis Montastruc; Olivier Rascol
Journal:  Mov Disord       Date:  2005-12       Impact factor: 10.338

8.  Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease.

Authors:  Jean-François Gagnon; Mélanie Vendette; Ronald B Postuma; Catherine Desjardins; Jessica Massicotte-Marquez; Michel Panisset; Jacques Montplaisir
Journal:  Ann Neurol       Date:  2009-07       Impact factor: 10.422

9.  Quantitative measurement of pain sensation in patients with Parkinson disease.

Authors:  R Djaldetti; A Shifrin; Z Rogowski; E Sprecher; E Melamed; D Yarnitsky
Journal:  Neurology       Date:  2004-06-22       Impact factor: 9.910

10.  Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

Authors:  K Stiasny-Kolster; Y Doerr; J C Möller; H Höffken; T M Behr; W H Oertel; G Mayer
Journal:  Brain       Date:  2004-11-17       Impact factor: 13.501

View more
  2 in total

1.  Inhibition of Spinal 5-HT3 Receptor and Spinal Dorsal Horn Neuronal Excitability Alleviates Hyperalgesia in a Rat Model of Parkinson's Disease.

Authors:  Cheng-Jie Li; Li-Ge Zhang; Lu-Bing Liu; Meng-Qi An; Li-Guo Dong; Han-Ying Gu; Yong-Ping Dai; Fen Wang; Cheng-Jie Mao; Chun-Feng Liu
Journal:  Mol Neurobiol       Date:  2022-09-27       Impact factor: 5.682

Review 2.  Towards optimising experimental quantification of persistent pain in Parkinson's disease using psychophysical testing.

Authors:  Rory V Smith; Patrick Wilkins; Kirsty Bannister; Tatum M Cummins
Journal:  NPJ Parkinsons Dis       Date:  2021-03-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.